Clinical trials and Research resources for COVID-19:
WHO is bringing the world’s scientists and global health professionals together to accelerate the research and development process, and develop new norms and standards to contain the spread of the coronavirus pandemic and help care for those affected.
The R&D Blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus. The solidarity of all countries will be essential to ensure equitable access to COVID-19 health products.
The mission of the WHO International Clinical Trials Registry Platform is to ensure that a complete view of research is accessible to all those involved in health care decision making. This will improve research transparency and will ultimately strengthen the validity and value of the scientific evidence base.
The registration of all interventional trials is a scientific, ethical and moral responsibility.
|What is a clinical trial?|
For the purposes of registration, a clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Clinical trials may also be referred to as interventional trials. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, etc. This definition includes Phase I to Phase IV trials.
|What is trial registration?|
WHO regards trial registration as the publication of an internationally-agreed set of information about the design, conduct and administration of clinical trials. These details are published on a publicly-accessible website managed by a registry conforming to WHO standards.
Other resources on coronavirus disease (COVID-19)
- Cambridge University Press
- Centers for Disease Control and Prevention
- Chinese Medical Association
- European Centre for Disease Prevention and Control (ECDC)
- JAMA Network
- The Lancet
- LITCOVID: US National Library of Medicine
- New England Journal of Medicine
- Oxford University Press
- Public Health England
- Springer Nature
- SSRN (Preprints)
- Recovery time for COVID-19: The recovery time for corona virus varies for MILD and CRITICAL:
Using available preliminary data, the median time from onset to clinical recovery for mild cases is approximately 2 weeks and is 3-6 weeks for patients with severe or critical disease.
The researchers and research laboratories are on a constant run to find newest information about this constantly mutating virus.Поділитися цим: